LOXL2 and head and neck squamous cell carcinoma: Another study evaluated the expression levels of exosome-derived Lysyl Oxidase Like 2 (LOXL2) protein, demonstrating that LOXL2 was significantly overexpressed in serum samples of the HNSCC patients compared to healthy individuals [234].